Abstract
During the last few years, high throughput RNA profiling technologies have become nearly indispensable tools in biomedical research. Optimization strategies for the different technologies and bioinformatics tools to mine the wealth of data have developed rapidly to meet the researchers need calling for more sophisticated clinical and pharmaceutical applications and a more integrated view of the cells primary molecules DNA, RNAs and proteins. Integrative network analyses based on quantitative expression data, and the integration of data gained from genome analysis defining the relationships between the cells transcriptome and proteome, are becoming the focus of current research. Key issues to resolve include method developments to optimize analysis of small amounts of tissue or cells and low-abundance messages, and minimize biological noise. DNA microarray technology, oligonucleotide-based microarrays in particular, holds much promise, but may still be largely unexploited. In the wake of experience gathered during expression profiling of human prostate tumors, tissues from human infectious disease models and experimental rodent systems, we discuss here a number of novel DNA microarray-based approaches that may be used in the near future to conduct hypothesis-driven transcriptome research aiming at quantitative models of genetic networks and at narrowing the gap between the transcriptome and the proteome. Such research may also establish microarray technology as indispensable for clinical research near the patients bedside.
Keywords: dna microarrays, quantitative transcriptome, biological networks, rna amplification, disease markers, methylation changes, non-coding rnas
Current Genomics
Title: DNA Microarrays: Perspectives for Hypothesis-Driven Transcriptome Research and for Clinical Applications
Volume: 4 Issue: 6
Author(s): M. Hergenhahn, K. Muhlemann, M. Hollstein and M. Kenzelmann
Affiliation:
Keywords: dna microarrays, quantitative transcriptome, biological networks, rna amplification, disease markers, methylation changes, non-coding rnas
Abstract: During the last few years, high throughput RNA profiling technologies have become nearly indispensable tools in biomedical research. Optimization strategies for the different technologies and bioinformatics tools to mine the wealth of data have developed rapidly to meet the researchers need calling for more sophisticated clinical and pharmaceutical applications and a more integrated view of the cells primary molecules DNA, RNAs and proteins. Integrative network analyses based on quantitative expression data, and the integration of data gained from genome analysis defining the relationships between the cells transcriptome and proteome, are becoming the focus of current research. Key issues to resolve include method developments to optimize analysis of small amounts of tissue or cells and low-abundance messages, and minimize biological noise. DNA microarray technology, oligonucleotide-based microarrays in particular, holds much promise, but may still be largely unexploited. In the wake of experience gathered during expression profiling of human prostate tumors, tissues from human infectious disease models and experimental rodent systems, we discuss here a number of novel DNA microarray-based approaches that may be used in the near future to conduct hypothesis-driven transcriptome research aiming at quantitative models of genetic networks and at narrowing the gap between the transcriptome and the proteome. Such research may also establish microarray technology as indispensable for clinical research near the patients bedside.
Export Options
About this article
Cite this article as:
Hergenhahn M., Muhlemann K., Hollstein M. and Kenzelmann M., DNA Microarrays: Perspectives for Hypothesis-Driven Transcriptome Research and for Clinical Applications, Current Genomics 2003; 4 (6) . https://dx.doi.org/10.2174/1389202033490231
DOI https://dx.doi.org/10.2174/1389202033490231 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>In Silico</i> Assessment of the Acute Toxicity of Chemicals: Recent Advances and New Model for Multitasking Prediction of Toxic Effect
Mini-Reviews in Medicinal Chemistry Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents
Current Medicinal Chemistry Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Current Cancer Drug Targets CD40L - A Multipotent Molecule for Tumor Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Current Neuropharmacology GPER and ER: Estrogen Receptors with Distinct Biological Roles in Breast Cancer
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Innovative Formulations for the Controlled and Site-specific Delivery of Antiinflammatory Drugs
Current Pharmaceutical Design Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism Recent Progress in Clinical Development of Therapeutic Antibodies Targeting Glycan-Binding Proteins
Current Drug Targets Signaling Pathways of the ING Proteins in Apoptosis
Current Drug Targets Peripheral Benzodiazepine Receptor (PBR) New Insight in Cell Proliferation and Cell Differentiation Review
Current Clinical Pharmacology Patent Selections
Recent Patents on Cardiovascular Drug Discovery Polypharmacology of Approved Anticancer Drugs
Current Drug Targets Equilibrative Nucleoside (ENTs) and Cationic Amino Acid (CATs) Transporters: Implications in Foetal Endothelial Dysfunction in Human Pregnancy Diseases
Current Vascular Pharmacology Review on Triggered Liposomal Drug Delivery with a Focus on Ultrasound
Current Cancer Drug Targets Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem
Current Pharmacogenomics and Personalized Medicine Environmental Factors Contributing to Susceptibility to Tuberculosis
Current Respiratory Medicine Reviews Molecular and Cellular Mechanisms of Hexavalent Chromium-Induced Lung Cancer: An Updated Perspective
Current Drug Metabolism Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry Synthetic Approaches to the 2006 New Drugs
Mini-Reviews in Medicinal Chemistry